A First in Human Study to Evaluate Safety, Tolerability, Pharmacology of HS-10390 in Healthy Subjects

Clinical trial NCT05942625 · RECRUITING

Trial details

NCT number: NCT05942625
Sponsor: Hansoh BioMedical R&D Company
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

IgA Nephropathy Focal Segmental Glomerulosclerosis

Start date: 2023-05-23
Primary completion: 2024-06-30
Enrollment: 84

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.